Vikas Dandekar

Editor - Pharma and Life Sciences, ET Prime

I have been tracking the Indian pharmaceutical industry for over two decades, seeing it transform from minnows to global scale. ET Prime is my second stint with the Times Group after heading the Econ ...

I have been tracking the Indian pharmaceutical industry for over two decades, seeing it transform from minnows to global scale. ET Prime is my second stint with the Times Group after heading the Economic Times’ health and pharma vertical in 2015. My other media stints include The Indian Express and business news channel CNBC TV18 as bureau chief. I have also reported on the pharmaceutical sector for seven years for paywalled global publications such as PharmAsia News, The Pink Sheet, and Scrip Intelligence, all part of Informa, the UK-based media and conference powerhouse. From keenly watched M&As to the intricacies of outcome-based pricing of newly patented drugs, healthcare costs, hospital services, the ethics of clinical trials, commercial strategies, patent battles, people movement, and medical devices, pharma excites me endlessly.

Read More Read Less

Stories by the author

• Regulator, cos discuss price hike for some cancer drugs

  
  06 Jun 2026 12:40 AM IST
• Corner Office Conversation: Habil Khorakiwala on India's First FDA-Approved Antibiotic

  
  04 Jun 2026 06:18 AM IST
• If you have the patience, you can achieve innovation milestones, says Wockhardt chairman Habil Khorakiwala

  
  02 Jun 2026 12:01 AM IST
• FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics market

  
  01 Jun 2026 05:01 AM IST
• Cipla is aiming for 40-50 global product filings in three years, says MD Achin Gupta

  
  29 May 2026 05:30 AM IST
• Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEO

  
  28 May 2026 11:57 PM IST
• Gene therapy for cholesterol: Initial test results cheer

  
  27 May 2026 05:30 AM IST
• From oncology to obesity, Pfizer bets big on India for its next growth wave

  
  14 May 2026 12:40 AM IST
• Zydus Lifesciences close to buying US oncology drug maker for $100 to 150 million: Sources

  
  13 May 2026 05:45 PM IST

• Deals

  How this man proved M&As need not be disasters even if tough

  
  10 mins read5 May 2026
• ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till date

  
  26 Apr 2026 09:16 PM IST
• Sun Pharma looks to outshine rival bids with $13 billion Organon offer

  
  24 Apr 2026 05:30 AM IST
• Quadria, PE funds eye stake in Samarth Lifesciences; deal may value firm at Rs 4,500 crore

  
  23 Apr 2026 06:00 AM IST
• Alkem Labs CEO Vikas Gupta may exit company

  
  22 Apr 2026 01:28 PM IST
• India medical tourism slips below pre-Covid peak amid geopolitics, visa delays and rising Asian competition

  
  18 Apr 2026 05:30 AM IST
• Semaglutide API price plunges amid GLP-1 rush

  
  17 Apr 2026 12:54 AM IST
• Funding for innovations key for India to remain vaccine leader: Cyrus Poonawalla

  
  16 Apr 2026 01:14 AM IST
• Dr Reddy's gets nod to roll out generic oral semaglutide drug

  
  16 Apr 2026 12:37 AM IST
• Iran war impact: Essential drugs may cost up to 5% more, for now

  
  15 Apr 2026 06:00 AM IST
• Social media is abuzz with weight-loss drug retatrutide and longevity goals. What is the drug all about?

  
  13 Apr 2026 12:15 AM IST
• Sun Pharma closes in on Organon buy, gets set for $12 billion binding bid

  
  10 Apr 2026 05:30 AM IST
• With sights on huge gains, Biocon to scale up AI focus

  
  08 Apr 2026 12:38 AM IST
• Cancer drug makers seek 50% price hike as platinum surge hits production viability

  
  06 Apr 2026 12:57 AM IST
• Morning Brief Podcast: Cricket & Corporate Leadership

  
  03 Apr 2026 06:20 AM IST
• Koye Pharma next on Warburg's health play

  
  31 Mar 2026 11:59 PM IST
• US-based Warburg Pincus in talks to buy Maneesh Pharma unit in Rs 1,800 crore deal

  
  25 Mar 2026 08:49 AM IST
• Rising costs of key chemicals choke production at drug ingredient makers

  
  25 Mar 2026 12:52 AM IST
• Corner Office Conversation: GV Prasad, Co-Chairman and Managing Director Dr Reddy’s Laboratories Ltd

  
  23 Mar 2026 06:24 AM IST
• Obesity bet may drive focus on chronic segment: Alkem Labs

  
  21 Mar 2026 01:07 AM IST
• Natco, Eris Life to launch slimming shots in both Vial and Pen formats

  
  21 Mar 2026 01:06 AM IST
• Morning Brief Podcast: Semaglutide Goes Generic: Big Pharma’s Moat Breaks

  
  19 Mar 2026 06:16 AM IST
• Ahead of its time, a GLP-1 drug almost made it out of India

  
  04 Mar 2026 12:10 AM IST
• Glenmark set to join peers in 'Semaglutide' push

  
  02 Mar 2026 12:21 AM IST
• All our AI models have scientists in loop, says MSD chief AI officer

  
  01 Mar 2026 06:30 PM IST
• CDSCO to create 1,500-member scientific cadre to fast-track drug approvals

  
  24 Feb 2026 12:18 AM IST
• Drug regulator cracks down hard on non-compliant cough syrup makers

  
  24 Feb 2026 12:13 AM IST
• Corner Office Conversation: Dilip Shanghvi, Chairman of Sun Pharma and Glenn Saldanha, MD at Glenmark Pharma

  
  23 Feb 2026 06:13 AM IST
• Indian pharma may take AI pill to cut time and costs in drug R&D

  
  17 Feb 2026 12:45 AM IST
• USV Pharma leads race to buy 85% stake in Wellbeing Nutrition at Rs 1,600 crore valuation

  
  12 Feb 2026 06:00 AM IST
• Warburg-Mubadala team up, emerge as frontrunner for Encube

  
  11 Feb 2026 12:42 AM IST
• Policy clarity helps protect pricing stability, ensure supply: Pharma companies

  
  07 Feb 2026 11:37 PM IST
• Sun Pharmaceutical to adopt a 'disciplined' approach to M&A: Dilip Shanghvi

  
  31 Jan 2026 11:39 PM IST
• Pitiless Cut: Johnson & Johnson’s broken hip implants and the cost of corporate negligence

  
  25 Jan 2026 08:55 AM IST
• Sun Pharma places non-binding offer for US-based Organon in its boldest global bet ever

  
  20 Jan 2026 05:30 AM IST
• Sun Pharma looks to rise in US with $10 billion Organon buy

  
  19 Jan 2026 04:00 AM IST
• Delhi HC seeks govt reply on plea against online diagnostic services

  
  05 Jan 2026 12:21 AM IST
• Jupiter Hospital, Reliance-backed co in race for Mumbai SevenHills

  
  26 Dec 2025 12:25 AM IST
• Bristol Myers lines up many launches for India with 'AI' speed

  
  24 Dec 2025 12:17 AM IST